The presented data indicate that pregnancy after completion of oncological treatment for breast cancer does not affect the prognosis of patients, regardless of BRCA1/2 gene mutation status and hormone receptor expression and does not affect the well-being of the children born. The gene discussed is NR4A1; the disease is breast cancer.